Hospital
Fayette Memorial Hospital Association INC.
Fayette Memorial Hospital Association INC. was paid $1.75M by Medicaid between Jan 2018 and Jul 2019, across 110 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 24% of everything it billed.
33Billing provider infoFAYETTE MEMORIAL HOSPITAL ASSOCIATION INC.
CONNERSVILLE, IN 47331
CONNERSVILLE, IN 47331
33aNPI1508825720assigned 03/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.75M
24GClaims73,668
24DCodes billed110
24AFirst – last monthJan 2018 – Jul 2019
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#49 of 69
Median peer was paid$9.76M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,840 | $1.03M | |
| 2019 | 17,828 | $723K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 24% | 10,091 | 7,157 | $418K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 4,053 | 2,787 | $219K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 2,623 | 2,276 | $189K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.3% | 2,535 | 1,949 | $162K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 1,673 | 1,411 | $93K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 4.9% | 2,003 | 998 | $86K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.9% | 1,977 | 1,265 | $85K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.8% | 626 | 568 | $67K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.5% | 678 | 542 | $45K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.4% | 418 | 372 | $42K |
| 59426 | 2.3% | 658 | 385 | $39K | |
| 59425 | 1.7% | 470 | 368 | $29K |
98 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 1,555 | $23K |
| G0378 | Hospital observation service, per hour | 1.0% | 128 | $18K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 441 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,399 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 737 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 588 | $15K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 736 | $14K |
| 64493 | <1% | 19 | $13K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 333 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 286 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 4,741 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,277 | $10K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 374 | $10K |
| Q3014 | Telehealth originating site facility fee | <1% | 234 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 669 | $8K |
| 64494 | <1% | 19 | $8K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 140 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 690 | $3K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 28 | $3K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 35 | $3K |
| 80074 | <1% | 75 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,936 | $3K |
| 80306 | <1% | 732 | $3K | |
| 87807 | <1% | 201 | $2K | |
| 80061 | Lipid panel | <1% | 743 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 875 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 818 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 17 | $2K |
| 84484 | <1% | 937 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 430 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 377 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 187 | $1K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 26 | $1K |
| 82550 | <1% | 1,121 | $1K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 29 | $1K |
| 74022 | <1% | 140 | $1K | |
| 87081 | <1% | 200 | $1K | |
| 87806 | <1% | 301 | $1K | |
| 83605 | <1% | 583 | $969.56 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 752 | $956.12 |
| 99201 | <1% | 23 | $879.90 | |
| 99188 | <1% | 74 | $879.90 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 216 | $873.89 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $813.02 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 69 | $752.76 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 54 | $709.92 |
| 80320 | <1% | 20 | $635.04 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 377 | $568.64 |
| 82553 | <1% | 442 | $544.71 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 35 | $535.54 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 404 | $526.38 |
| 81001 | <1% | 1,050 | $522.87 | |
| 81025 | <1% | 460 | $511.01 | |
| 87522 | Neg quan hep c or qual rna | <1% | 20 | $507.87 |
| 80076 | <1% | 449 | $507.06 | |
| 83655 | <1% | 46 | $500.25 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 197 | $439.53 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 86 | $409.32 |
| 81003 | <1% | 1,488 | $378.39 | |
| 83690 | <1% | 555 | $366.46 | |
| 84439 | <1% | 224 | $298.16 | |
| 82150 | <1% | 341 | $271.60 | |
| 85730 | <1% | 202 | $248.98 | |
| 86592 | <1% | 197 | $227.27 | |
| 85610 | <1% | 308 | $221.10 | |
| 85379 | <1% | 165 | $207.06 | |
| 85018 | <1% | 58 | $128.14 | |
| 81002 | <1% | 162 | $125.53 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 14 | $102.06 |
| 85027 | <1% | 33 | $54.18 | |
| 82728 | <1% | 38 | $48.99 | |
| 84100 | <1% | 26 | $36.33 | |
| 84702 | <1% | 23 | $27.66 | |
| 85652 | <1% | 110 | $20.06 | |
| 86850 | <1% | 21 | $15.15 | |
| 87186 | <1% | 16 | $12.37 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 324 | $11.04 |
| 83735 | <1% | 25 | $8.02 | |
| 82950 | <1% | 13 | $5.68 | |
| 86901 | <1% | 22 | $3.58 | |
| 86900 | <1% | 22 | $3.58 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 447 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 650 | $0.00 |
| 90686 | 0% | 43 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 138 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 206 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 205 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 25 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 19 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 41 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 15 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 370 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 739 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 425 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 76 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 68 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 38 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWHITE, RANDY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Monroe County Ambulance Service | Madisonville, TN | $2.50M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.